Atopix Therapeutics – Treating inflammatory and respiratory diseases
Chiesi acquired Atopix
Atopix is developed a promising pipeline of novel, small-molecule drugs to treat inflammatory and respiratory diseases.
Industry
Therapeutics
Case facts
Location
United Kingdom
Status
Exit October 2012
